Early Anatomy Scan for Evaluation of Obese Pregnant Women (EASE-O)
- Conditions
- Obesity
- Interventions
- Diagnostic Test: Group 1 (First trimester ultrasound)Diagnostic Test: Group 2 (Second trimester anatomy ultrasound)
- Registration Number
- NCT04639973
- Brief Summary
The purpose of this study is to assess the feasibility of ultrasound in the first trimester, assess the completion rate of ultrasounds for fetal anatomy in the first trimester compared to completion rates of ultrasounds for fetal anatomy in the second trimester and to assess the completion rate of the combination of one ultrasound in the first trimester and one in the second trimesters compared to the individual completion rates of both evaluations in obese pregnant women.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 128
- BMI greater than or equal to 35
- Presented for ultrasound before 14 weeks at The University of Texas Professional Building, Memorial City, Bellaire, or Lyndon-Baines Johnson clinics
- Primary language is English or Spanish
- Consent to an extra transvaginal ultrasound if needed
- Singleton gestation
- No previous anomalies known before consent
- Missed abortion (nonviable pregnancy)
- Elective abortion after recruitment
- Missed abortion after first trimester ultrasound
- Did not receive second trimester ultrasound
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group 1 (First trimester ultrasound) Group 1 (First trimester ultrasound) - Group 2 (Second trimester anatomy ultrasound) Group 2 (Second trimester anatomy ultrasound) -
- Primary Outcome Measures
Name Time Method Completion Rate for First Trimester Scans 12-14 weeks of pregnancy Completion rate is reported as the number of scans that see all the views divided by total number of scans in that group
Completion Rate for Second Trimester Scans 18-22 weeks of pregnancy Completion rate is reported as the number of scans that see all the views divided by total number of scans.
- Secondary Outcome Measures
Name Time Method Number of Anomalies Missed in First Trimester Group Scans 12-14 weeks of pregnancy Number of Anomalies Missed in Second Trimester Group Scans 12-22 weeks of pregnancy Number of Participants With Infants Who Survive 9 months from randomization Gestational Age at Delivery at the time of delivery (about 40 weeks of pregnancy) Hospital Length of Stay from time of hospital admission to discharge (about 0 to 365 days after birth) Number of Participants Who Were Very Satisfied With Ultrasound as Measured by the Standardized Survey in the First Trimester Group Scans 6 months from randomization The survey asks "Overall, how satisfied were you with today's ultrasound?," and participants selected one of the below choices. Number who chose "Very Satisfied" is reported.
1. Very satisfied
2. Somewhat satisfied
3. Neither satisfied nor dissatisfied
4. Somewhat dissatisfied
5. Very dissatisfiedCompletion Rate of First Trimester and Second Trimester Scans 12-22 weeks of pregnancy This outcome is reported as \[(# of completed 1st tri anatomy scans) + (# of completed 2nd tri anatomy scans in women without a completed first tri anatomy scan)\]/(total number of women in first trimester group).
Time Taken to Complete Scan in the First Trimester Ultrasound Group 12-14 weeks of pregnancy Number of Anomalies Identified in First Trimester Group Scans 12-14 weeks of pregnancy Number of Anomalies Identified in Second Trimester Group Scans 12-22 weeks of pregnancy Number of Participants With Infants With Neonatal Morbidities 9 months from randomization Neonatal morbidities include hypoglycemia
Cost of Intervention Compared to Usual Care from 12-22 weeks of pregnancy cost benefit analysis based on whether more ultrasounds were done in cases of early discovery of anomalies
Number of Participants With Infants Admitted to the Neonatal Intensive Care Unit (NICU) at the time of NICU admission (about 0 to 28 days after birth)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
The University of Texas Health Science Center at Houston
🇺🇸Houston, Texas, United States